文献速递临床试验与 GCP

BioClock优化成人抑郁症明亮光照治疗:一项多中心随机临床试验方案,研究治疗策略、反应预测因素及时间生物学与神经生物学机制

BioClock-optimizing Bright Light Therapy for adults with depression: a study protocol for a multicenter randomized clinical trial on treatment strategies, response predictors, and chronobiological and neurobiological mechanisms.
PubMed 文献 · Trials · 2025-10-14

这项多中心随机对照试验将纳入231例目前处于抑郁发作的单相或双相抑郁症患者,随机分配至三种明亮光照治疗(BLT)干预之一:传统家庭BLT、在LightCafé中实施的BLT,或LightCafé BLT并加用蓝光阻挡眼镜实现个性化光照与黑暗时序。治疗时长根据预设的反应定义为一至三周,主要结局为盲法评估者评定的抑郁症状变化。

要点

  • 该试验首次直接比较不同BLT实施模式,包括LightCafé设置。
  • 治疗时长根据预设的参与者反应定义为一至三周。
  • 主要结局为盲法评估者评定的抑郁症状变化。

核心结论

  • 该试验旨在识别BLT反应的预测因素,研究时间生物学与神经生物学机制,并为优化BLT以适应不同患者群体提供见解。
  • 结果将为临床指南提供信息,并提升BLT的可及性与有效性。

研究设计与样本

  • 多中心随机对照试验,将纳入231例目前处于抑郁发作的单相或双相抑郁症患者。
  • 参与者被随机分配至三种BLT干预之一:传统家庭BLT、在LightCafé中实施的BLT,或LightCafé BLT并加用蓝光阻挡眼镜实现个性化光照与黑暗时序。
  • 治疗时长根据预设的参与者反应定义为一至三周。
  • 主要结局为盲法评估者评定的抑郁症状变化。
  • 次要结局包括主观与客观睡眠测量、基于褪黑素模式和体动记录仪得出的昼夜节律参数以及功能结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bright Light Therapy (BLT) is an effective treatment for various mood disorders, but challenges remain in optimizing its real-world administration, predicting individual responses, and understanding its mechanisms. METHODS: This multicenter randomized controlled trial will enroll 231 patients with unipolar or bipolar depression, all currently experiencing a depressive episode. Participants will be randomized to one of three BLT interventions: (1) traditional home-based BLT, (2) BLT administered in the LightCafé-a novel setting promoting social interaction and lifestyle support, or (3) LightCafé BLT with personalized timing of both light and darkness by adding the use of blue light blocking glasses. The treatment duration will range from one to three weeks, based on preset definitions of participant's response. The primary outcome is the change in depressive symptoms, assessed by a blinded rater. Secondary outcomes include subjective and objective sleep measures, circadian rhythm parameters from melatonin patterns and actigraphy, and functional outcomes. Change processes will be assessed using ecological momentary assessments of daily affect and energy levels, light exposure sensors, and via brain imaging. DISCUSSION: This trial is the first to directly compare different BLT administration models, including a LightCafé setting. It aims to identify predictors of BLT response, investigate chronobiological and neurobiological mechanisms, and provide insights to optimize BLT for diverse patient populations. The results will inform clinical guidelines and enhance BLT's accessibility and effectiveness. TRIAL REGISTRATION: Registered on July 14, 2023, at clinicaltrials.gov under number NCT05958940.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Visser E, Rus-Oswald OG, van der Does AJW, et al. BioClock-optimizing Bright Light Therapy for adults with depression: a study protocol for a multicenter randomized clinical trial on treatment strategies, response predictors, and chronobiological and neurobiological mechanisms. Trials. 2025. PMID: 41088238. doi:10.1186/s13063-025-08984-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。